NDC 50228-0175-01
bupropion hydrochloride 150 mg/1 TABLET, FILM COATED, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
50228-0175-01
Generic Name
bupropion hydrochloride
Brand Name
Bupropion Hydrochloride SR
Strength
150 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
ScieGen Pharmaceuticals, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Bupropion hydrochloride extended-release tablets (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies ( 14 )] . The efficacy of bupropion hydrochloride extended-release table…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All bupropion hydrochloride Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other bupropion hydrochloride NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 50228-0175-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).